Top Story

Mohs micrographic surgery for melanoma increased from 2003 to 2008

May 29, 2015

Use of Mohs micrographic surgery to treat melanomas increased by 60% between 2003 and 2008, according to data from the National Cancer Institute.

Researchers used data from the NCI’s Surveillance, Epidemiology and End Results (SEER) program to conduct a retrospective analysis of patients who received surgical excision using either Mohs micrographic surgery (MMS) or wide excision as treatment for invasive melanoma and melanoma in situ (MIS). They identified 195,768 melanomas from 17 SEER cancer registries diagnosed from 2003 to 2009, including 117,764 invasive melanomas (60.2%).

Robert H.I. Andtbacka, MD In the JournalsPerspective

Higher response rate seen with T-VEC in advanced melanoma

May 28, 2015
Patients with unresected stage IIIB to IV melanoma who were treated with talimogene laherparepvec experienced a higher durable response rate than patients treated with…
Elaine Mardis, PhD In the Journals

Personalized vaccines provoke antitumor activity in melanoma

May 27, 2015
A dendritic cell vaccine targeted at patient-specific neoantigens expanded the antitumor immune response in patients with melanoma, according to study…
Arul M. Chinnaiyan, MD, PhD Cover StoryPublication Exclusive

Despite promise, ‘maximum potential’ of precision medicine yet to be reached

HemOnc Today, May 25, 2015
Precision medicine has garnered tremendous public attention since President Barack Obama established it as a national priority during his State of the Union address.The…
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
VIDEO: Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting

VIDEO: Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting

April 26, 2015
NEW YORK — Sanjiv S. Agarwala, MD, professor of medicine at Temple University School of Medicine, chief of…
More »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
In the Journals

Mohs micrographic surgery for melanoma increased from 2003 to 2008

May 29, 2015
Use of Mohs micrographic surgery to treat melanomas increased by 60% between 2003 and 2008, according to data from the National Cancer Institute…
Robert H.I. Andtbacka, MD In the JournalsPerspective

Higher response rate seen with T-VEC in advanced melanoma

May 28, 2015
Patients with unresected stage IIIB to IV melanoma who were treated with talimogene laherparepvec experienced a higher durable response rate than…
Elaine Mardis, PhD In the Journals

Personalized vaccines provoke antitumor activity in melanoma

May 27, 2015
A dendritic cell vaccine targeted at patient-specific neoantigens expanded the antitumor immune response in patients with melanoma, according to…
Arul M. Chinnaiyan, MD, PhD Cover StoryPublication Exclusive

Despite promise, ‘maximum potential’ of precision medicine yet to be reached

HemOnc Today, May 25, 2015
Precision medicine has garnered tremendous public attention since President Barack Obama established it as a national priority during his State of…

Keytruda recommended for approval in Europe as advanced melanoma treatment

May 22, 2015
Merck announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion in…
In the Journals

Reflectance confocal microscopy diagnostic criteria reproducibly recognized among users

May 22, 2015
Certain reflectance confocal microscopy diagnostic criteria for melanoma and basal cell carcinoma were reproducibly recognized among users of the…
In the Journals

Patients prefer expediency of telephone communication to receive skin biopsy results

May 19, 2015
Individuals awaiting skin biopsy results to rule out melanoma preferred telephone and electronic notifications to face-to-face discussions, according…
In the Journals

Study: No need to determine histological parameters prior to noninvasive treatment of superficial BCC

May 18, 2015
There was no significant need to determine tumor thickness or adnexal extension prior to deciding on noninvasive treatment of superficial basal cell…
Arielle N.B. Kavar, MD In the Journals

ASDS consensus recommendations include Mohs micrographic surgery for high-risk BCCs

May 14, 2015
Mohs micrographic surgery is the treatment of choice for high-risk basal cell carcinomas and those located in cosmetically sensitive locations…
Meeting News Coverage

Nicotinamide reduces rate of new nonmelanoma skin cancers in high-risk patients

May 14, 2015
Nicotinamide, a form of vitamin B3, conferred a 23% reduction in the rate of new, nonmelanoma skin cancers in high-risk patients who previously had…
More Headlines »
morganatic-roan